In the multifaceted drug development arena, a successful clinical trial paves the way for potential FDA drug candidate approval. For perspective, a successful drug development cycle typically extends for 10 to 15 years. This complex process costs approximately $1 billion per approved drug candidate.
However, most drug candidates never make it through the clinical trial phase. In fact, 90 percent of in-development drugs fail to successfully navigate this multi-year process.
This less-than-optimal outcome may result from one or more contributing factors. Leen Kawas, Ph. D. discussed the reasons for clinical trial failures and offered recommendations to help improve trial outcomes.
Read the full article here: https://californiarecorder.com/leen-kawas-details-key-strategies-for-increasing-clinical-trials-success-rates/
Comments